About the Authors
- Paul W. Hollenbach
-
Affiliation Celgene Corporation, San Francisco, California, United States of America
- Aaron N. Nguyen
-
Affiliation Celgene Corporation, San Francisco, California, United States of America
- Helen Brady
-
Affiliation Celgene Corporation, San Francisco, California, United States of America
- Michelle Williams
-
Affiliation Department of Biochemistry and Molecular Genetics, University of Colorado Denver School of Medicine, Aurora, Colorado, United States of America
- Yuhong Ning
-
Affiliation Celgene Corporation, San Francisco, California, United States of America
- Normand Richard
-
Affiliation Celgene Corporation, San Francisco, California, United States of America
- Leslie Krushel
-
Affiliation Department of Biochemistry and Molecular Genetics, University of Colorado Denver School of Medicine, Aurora, Colorado, United States of America
- Sharon L. Aukerman
-
Affiliation Celgene Corporation, San Francisco, California, United States of America
- Carla Heise
-
Affiliation Celgene Corporation, San Francisco, California, United States of America
- Kyle J. MacBeth
-
* E-mail: kmacbeth@celgene.com
Affiliation Celgene Corporation, San Francisco, California, United States of America
Competing Interests
Vidaza is a marketed product with azacitidine as the active pharmaceutical ingredient. Dacogen is a marketed product with decitabine as the active pharmaceutical ingredient. The authors are able to adhere to the PLoS ONE policies on sharing data and materials. P.W.H., A.N.N., H.B., Y.N., N.R., S.L.A., C.H., and K.J.M. are employees of Celgene and as such own stock in the company. M.W. and L.K. received research support from Celgene.
Author Contributions
Conceived and designed the experiments: PWH ANN LK SLA CH KJM. Performed the experiments: PWH ANN HB MW NR. Analyzed the data: PWH ANN HB MW YN NR LK SLA CH KJM. Wrote the paper: PWH ANN KJM. Interpretation of data: PWH ANN HB MW YN NR LK SLA CH KJM. Critical review of manuscript content: PWH ANN HB MW YN NR LK SLA CH KJM.